BACKGROUND/AIMS: Static cold storage (SCS) of the liver for transplantation is limited by time. Continuation of metabolic activity leads to depletion of energy stores and loss of cellular function, which results in poor post-transplant function. Machine perfusion (MP) applied at the end of preservation may improve the viability of marginal liver grafts and provides information on the quality of the organ. We attempt to define the limits to SCS in terms of easily measurable perfusion parameters and investigate whether MP can improve liver viability. METHODS: Rat livers were cold-stored for 0, 24, 48, 72, and 120 h, after which they were treated with subnormothermic machine perfusion (SNMP). Livers cold-stored for 48 and 72 h were transplanted orthotopically with or without SNMP. During SNMP easily measurable parameters were monitored and adenosine triphosphate (ATP) content was measured following preservation and SNMP. RESULTS: ATP increased significantly during SNMP, but the recovered ATP content deteriorated with increased duration of SCS, with minimal improvement after 72 h of SCS. Vascular resistance during SNMP increased with extended preservation. After 48 h of SCS, orthotopic transplantation survival increased significantly from 50% to 100% with SNMP, but did not improve after 72 h. CONCLUSIONS: Vascular resistance and ATP recovery suggest a decrease in viability after 48 h of SCS. Survival data confirms the loss of post-transplant graft function and supports the use of ATP and vascular resistance as useful indicators. Further, we show that the recoverability of a liver using SNMP is limited to 48 h of SCS.
BACKGROUND/AIMS: Static cold storage (SCS) of the liver for transplantation is limited by time. Continuation of metabolic activity leads to depletion of energy stores and loss of cellular function, which results in poor post-transplant function. Machine perfusion (MP) applied at the end of preservation may improve the viability of marginal liver grafts and provides information on the quality of the organ. We attempt to define the limits to SCS in terms of easily measurable perfusion parameters and investigate whether MP can improve liver viability. METHODS:Rat livers were cold-stored for 0, 24, 48, 72, and 120 h, after which they were treated with subnormothermic machine perfusion (SNMP). Livers cold-stored for 48 and 72 h were transplanted orthotopically with or without SNMP. During SNMP easily measurable parameters were monitored and adenosine triphosphate (ATP) content was measured following preservation and SNMP. RESULTS:ATP increased significantly during SNMP, but the recovered ATP content deteriorated with increased duration of SCS, with minimal improvement after 72 h of SCS. Vascular resistance during SNMP increased with extended preservation. After 48 h of SCS, orthotopic transplantation survival increased significantly from 50% to 100% with SNMP, but did not improve after 72 h. CONCLUSIONS: Vascular resistance and ATP recovery suggest a decrease in viability after 48 h of SCS. Survival data confirms the loss of post-transplant graft function and supports the use of ATP and vascular resistance as useful indicators. Further, we show that the recoverability of a liver using SNMP is limited to 48 h of SCS.
Authors: Charles J Imber; Shawn D St Peter; Inigo Lopez de Cenarruzabeitia; Dave Pigott; Tim James; Richard Taylor; James McGuire; David Hughes; Andrew Butler; Michael Rees; Peter J Friend Journal: Transplantation Date: 2002-03-15 Impact factor: 4.939
Authors: L Wang; S Florman; S Roayaie; J Basile; Z Y Zhang; J Machac; P Boros; C M Miller Journal: Transplantation Date: 1998-09-15 Impact factor: 4.939
Authors: N V Jamieson; R Sundberg; S Lindell; K Claesson; J Moen; P K Vreugdenhil; D G Wight; J H Southard; F O Belzer Journal: Transplantation Date: 1988-10 Impact factor: 4.939
Authors: Hongzhi Xu; Tim Berendsen; Karen Kim; Alejandro Soto-Gutiérrez; Francios Bertheium; Martin L Yarmush; Martin Hertl Journal: J Surg Res Date: 2011-10-24 Impact factor: 2.192
Authors: R Adam; H Bismuth; T Diamond; B Ducot; M Morino; I Astarcioglu; M Johann; D Azoulay; L Chiche; Y M Bao Journal: Lancet Date: 1992-12-05 Impact factor: 79.321
Authors: B G Bruinsma; H Yeh; S Ozer; P N Martins; A Farmer; W Wu; N Saeidi; S Op den Dries; T A Berendsen; R N Smith; J F Markmann; R J Porte; M L Yarmush; K Uygun; M-L Izamis Journal: Am J Transplant Date: 2014-04-23 Impact factor: 8.086
Authors: Bote G Bruinsma; Tim A Berendsen; Maria-Louisa Izamis; Heidi Yeh; Martin L Yarmush; Korkut Uygun Journal: Nat Protoc Date: 2015-02-18 Impact factor: 13.491
Authors: Bote G Bruinsma; James H Avruch; Gautham V Sridharan; Pepijn D Weeder; Marie Louise Jacobs; Kerry Crisalli; Beth Amundsen; Robert J Porte; James F Markmann; Korkut Uygun; Heidi Yeh Journal: Transplantation Date: 2017-07 Impact factor: 4.939